| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human B-cell CLL/lymphoma 9 protein (BCL9) , partial |
|---|
| Description | MW: 149,290 Da. Purity >85% (SDS-PAGE). BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. |
|---|
| Size | 0.5 mg (E-Coli), 0.05 mg (Baculovirus), 0.5 mg (Yeast), 0.05 mg (Mammalian-Cell), 1 mg (E-Coli) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [B-cell CLL/lymphoma 9 protein; B-cell CLL/lymphoma 9 protein; B-cell CLL/lymphoma 9 protein; B cell CLL/lymphoma 9; Protein legless homolog] |
|---|
| Gene, Accession, CAS # | BCL9, Gene ID: 607, Accession: NP_004317.2 |
|---|
| Catalog # | MBS1246077 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human B-cell CLL/lymphoma 9 protein (BCL9) , partial from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|